Value Fund L. P. Biotechnology serves as Executive at AEOLUS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Value Fund L. P. Biotechnology has executed 256 insider transactions totaling $352.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 9, 2010 involved selling 23,000 shares valued at $63.5K.
Value Fund L. P. Biotechnology currently holds 4,058,854 shares of AEOLUS PHARMACEUTICALS, INC. (AOLS.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Value Fund L. P. Biotechnology has been a net seller of AOLS.OB stock. They have purchased $83.9M and sold $268.8M worth of shares.
Value Fund L. P. Biotechnology's most recent insider trade was on Apr 9, 2010, when they sold 23,000 shares at $2.76 per share.
Get notified when new Form 4 filings are submitted
| $2.70 |
| Discretionary |
| Mar 30, 2010 | NBIX | $164.7K | Sale | 61,000 | $2.70 | Discretionary |
| Mar 30, 2010 | NBIX | $67.5K | Sale | 25,000 | $2.70 | Discretionary |
| Mar 30, 2010 | NBIX | $48.6K | Sale | 18,000 | $2.70 | Discretionary |
| Sep 17, 2009 | ARQL | $11.0M | Sale | 2,100,000 | $5.25 | Discretionary |
| Sep 17, 2009 | ARQL | $4.8M | Sale | 920,000 | $5.25 | Discretionary |
| Sep 17, 2009 | ARQL | $3.5M | Sale | 660,000 | $5.25 | Discretionary |
| Aug 6, 2009 | DVAX | $1.0K | Sale | 500 | $2.03 | Discretionary |
| Aug 6, 2009 | DVAX | $2.0K | Sale | 1,000 | $2.03 | Discretionary |
| Aug 6, 2009 | DVAX | $4.1K | Sale | 2,000 | $2.03 | Discretionary |
| Aug 5, 2009 | DVAX | $464.0K | Sale | 232,000 | $2.00 | Discretionary |
| Aug 5, 2009 | DVAX | $194.0K | Sale | 97,000 | $2.00 | Discretionary |
| Aug 5, 2009 | DVAX | $134.0K | Sale | 67,000 | $2.00 | Discretionary |
| Jul 14, 2009 | TRGT | $6.0K | Purchase | 2,000 | $2.99 | Discretionary |
| Jul 14, 2009 | TRGT | $4.5K | Purchase | 1,516 | $2.99 | Discretionary |
| Jul 14, 2009 | TRGT | $17.9K | Purchase | 6,000 | $2.99 | Discretionary |
| Dec 30, 2008 | NBIX | $19.6K | Purchase | 7,000 | $2.80 | Discretionary |
| Dec 30, 2008 | NBIX | $5.6K | Purchase | 2,000 | $2.80 | Discretionary |
| Dec 30, 2008 | NBIX | $4.5K | Purchase | 1,600 | $2.80 | Discretionary |
| Nov 26, 2008 | CRXX | $490 | Purchase | 1,000 | $0.49 | Discretionary |
| Nov 26, 2008 | CRXX | $2.0K | Purchase | 4,000 | $0.49 | Discretionary |
| Nov 26, 2008 | CRXX | $784 | Purchase | 1,600 | $0.49 | Discretionary |
| Nov 24, 2008 | CRXX | $9.0K | Purchase | 20,100 | $0.45 | Discretionary |
| Nov 24, 2008 | CRXX | $22.1K | Purchase | 49,000 | $0.45 | Discretionary |
| Nov 24, 2008 | CRXX | $6.3K | Purchase | 14,000 | $0.45 | Discretionary |
| Nov 21, 2008 | CRXX | $3.1K | Purchase | 7,000 | $0.45 | Discretionary |
| Nov 21, 2008 | CRXX | $1.4K | Purchase | 3,000 | $0.45 | Discretionary |
| Nov 21, 2008 | CRXX | $900 | Purchase | 2,000 | $0.45 | Discretionary |
| Nov 19, 2008 | ARQL | $183.9K | Purchase | 69,413 | $2.65 | Discretionary |